l General Information |
Product Name | Pitavastatin Calcium |
General description | Pitavastatin calcium is a highly effective HMG-CoA reductase inhibitor. |
Synonym | calcium;(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoate; NK-104 |
Purity | ≥99.0%(HPLC) | CAS Number | 147526-32-7 |
Formula | C50H46CaF2N2O8 | Molecular Weight | 880.999 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | White or almost white solid |
Solubility(25℃) | DMSO | ≥45mg/mL |
Ethanol | Very slightly soluble |
Water | Insoluble |
l Biological Information |
Biochem/Physiol Actions | Pitavastatin Calcium is a calcium salt formulation of pitavastatin, a novel statin that induces plaque regression and elevates HDL-cholesterol levels. |
Application | Hydroxymethylglutaryl-CoA Reductase Inhibitors Compounds that inhibit HMG-CoA reductases. They have been shown to directly lower cholesterol synthesis. |
l Packaging & Storage |
Packaging | 50mg; 250mg; 1g |
Storage temp. | 0-5℃ |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
